找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: New Data and Updates for I-VII, III-V and II-VI Compounds; Volume 44, Subvolume U. R?ssler Book 20111st edition Springer-Verlag Berlin Heid

[復(fù)制鏈接]
查看: 12670|回復(fù): 35
樓主
發(fā)表于 2025-3-21 16:20:21 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱New Data and Updates for I-VII, III-V and II-VI Compounds
副標(biāo)題Volume 44, Subvolume
編輯U. R?ssler
視頻videohttp://file.papertrans.cn/665/664976/664976.mp4
概述Established and reliable, yet recent data are given..Renowned scientists have selected, evaluated and compiled the complex information found in literature and journals discharging the user from the bu
叢書名稱Landolt-B?rnstein: Numerical Data and Functional Relationships in Science and Technology - New Serie
圖書封面Titlebook: New Data and Updates for I-VII, III-V and II-VI Compounds; Volume 44, Subvolume U. R?ssler Book 20111st edition Springer-Verlag Berlin Heid
描述The Landolt-B?rnstein subvolume III/44D is the fourth part of an update to the existing eight volumes III/41 about Semiconductors and contains New Data and Updates for III-V, II-VI and I-VII compounds. Each compound is described with respect to its properties, the corresponding references are provided.
出版日期Book 20111st edition
版次1
doihttps://doi.org/10.1007/978-3-642-14148-5
isbn_ebook978-3-642-14148-5Series ISSN 1615-1844 Series E-ISSN 1616-9522
issn_series 1615-1844
copyrightSpringer-Verlag Berlin Heidelberg 2011
The information of publication is updating

書目名稱New Data and Updates for I-VII, III-V and II-VI Compounds影響因子(影響力)




書目名稱New Data and Updates for I-VII, III-V and II-VI Compounds影響因子(影響力)學(xué)科排名




書目名稱New Data and Updates for I-VII, III-V and II-VI Compounds網(wǎng)絡(luò)公開度




書目名稱New Data and Updates for I-VII, III-V and II-VI Compounds網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱New Data and Updates for I-VII, III-V and II-VI Compounds被引頻次




書目名稱New Data and Updates for I-VII, III-V and II-VI Compounds被引頻次學(xué)科排名




書目名稱New Data and Updates for I-VII, III-V and II-VI Compounds年度引用




書目名稱New Data and Updates for I-VII, III-V and II-VI Compounds年度引用學(xué)科排名




書目名稱New Data and Updates for I-VII, III-V and II-VI Compounds讀者反饋




書目名稱New Data and Updates for I-VII, III-V and II-VI Compounds讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:26:16 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:16:36 | 只看該作者
tients as therapeutic substances in itself already justifies at least some legal control. The human origin of these substances and their natural scarcity are further reasons for interference by society and the legislator.
地板
發(fā)表于 2025-3-22 06:21:57 | 只看該作者
tients as therapeutic substances in itself already justifies at least some legal control. The human origin of these substances and their natural scarcity are further reasons for interference by society and the legislator.
5#
發(fā)表于 2025-3-22 09:16:50 | 只看該作者
t into what actually happens during disciplinary moments that ultimately leads to the disproportional tracking of particular students into exclusionary school disciplinary consequences, which funnels an undercl978-94-6209-449-9Series ISSN 2214-9864 Series E-ISSN 2214-9872
6#
發(fā)表于 2025-3-22 14:43:00 | 只看該作者
7#
發(fā)表于 2025-3-22 17:24:09 | 只看該作者
8#
發(fā)表于 2025-3-22 23:16:14 | 只看該作者
9#
發(fā)表于 2025-3-23 02:45:22 | 只看該作者
a and hyperchloremia. Further research is warranted to determine the optimal agent and their best means of administration (boluses vs. continuous infusions) for each neurocritical condition. More extensive clinical trials are needed to address long-term outcomes, adverse events, and quality of life with both agents.
10#
發(fā)表于 2025-3-23 08:38:54 | 只看該作者
view on balanced intravenous solutions, firstly, by providing a physiological background of balanced solutions; secondly, by summarizing their potential pathophysiologic effects; and lastly, by presenting the clinical evidence available at the present time to support or refute their use in specific neurosurgical scenarios.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-24 16:57
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
正定县| 迁西县| 遂川县| 绥德县| 尤溪县| 明溪县| 扶沟县| 罗定市| 武鸣县| 靖远县| 四平市| 奉新县| 茌平县| 麟游县| 景洪市| 泾阳县| 安丘市| 大关县| 安乡县| 石屏县| 邵阳市| 中牟县| 霍林郭勒市| 汕尾市| 黄山市| 吉林省| 天峻县| 衡水市| 金沙县| 扬州市| 宝坻区| 扶余县| 台中市| 威海市| 嘉定区| 岗巴县| 阳高县| 襄城县| 安西县| 司法| 萍乡市|